Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 déc. 2019 08h00 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at Two Upcoming Medical Conferences

SAN DIEGO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it...
18 nov. 2019 08h00 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Named a San Diego Metro Area Top Workplace for the Third Consecutive Year

SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...
07 nov. 2019 21h17 HE | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Third Quarter 2019 Financial Results

SAN DIEGO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
05 nov. 2019 08h00 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Hosting Key Opinion Leader Meeting on Rezafungin and Cloudbreak Programs

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it...
03 oct. 2019 10h22 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present New Clinical and Preclinical Data at Two Upcoming Medical Conferences

SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it...
16 sept. 2019 16h05 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that Paul...
08 août 2019 16h07 HE | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial...
07 août 2019 07h30 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
29 juil. 2019 07h00 HE | Source: Cidara Therapeutics, Inc.

Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin

Data from second part of successful Phase 2 STRIVE trial further substantiate the efficacy, safety and tolerability of once-weekly rezafungin for first-line treatment of invasive Candida infections ...
09 mai 2019 16h13 HE | Source: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...

Page précédente